Commission Regulation (EU) 2017/626 of 31 March 2017 amending Annexes II and III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for acetamiprid, cyantraniliprole, cypermethrin, cyprodinil, difenoconazole, ethephon, fluopyram, flutriafol, fluxapyroxad, imazapic, imazapyr, lambda-cyhalothrin, mesotrione, profenofos, propiconazole, pyrimethanil, spirotetramat, tebuconazole, triazophos and trifloxystrobin in or on certain products
Proposed act with possible EEA relevance
Act under scrutiny by EEA EFTA
Draft Joint Committee Decision (JCD) under consideration
Entry into force of Joint Committee Decision (JCD) pending
Incorporated into the EEA Agreement and in force
Incorporated into the EEA Agreement but no longer in force
Legal status
EU legal act incorporated into the EEA Agreement by a Joint Committee Decision (JCD)
Area (EEA Agreement)
II Technical Regulations, Standards, Testing and Certification
II.XII Foodstuffs
Joint committee decision (JCD)
181/2017
In force in the EEA
Yes
Legal Documents
Commission Regulation (EU) 2017/626 of 31 March 2017 amending Annexes II and III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for acetamiprid, cyantraniliprole, cypermethrin, cyprodinil, difenoconazole, ethephon, fluopyram, flutriafol, fluxapyroxad, imazapic, imazapyr, lambda-cyhalothrin, mesotrione, profenofos, propiconazole, pyrimethanil, spirotetramat, tebuconazole, triazophos and trifloxystrobin in or on certain products
Reglugerð framkvæmdastjórnarinnar (ESB) 2017/626 frá 31. mars 2017 um breytingu á II. og III. viðauka við reglugerð Evrópuþingsins og ráðsins (EB) nr. 396/2005 að því er varðar hámarksgildi leifa fyrir asetamípríð, sýantranilípról, sýpermetrín, sýpródiníl, dífenókónasól, etefón, flúópýram, flútríafól, flúxapýroxað, imasapik, imasapýr, lambda-sýhalótrín, mesótríón, prófenófos, própíkónasól, pýrimetaníl, spírótetramat, tebúkónasól, tríasófos og trífloxýstróbín í eða á tilteknum afurðum
Verordnung (EU) 2017/626 der Kommission vom 31. März 2017 zur Änderung der Anhänge II und III der Verordnung (EG) Nr. 396/2005 des Europäischen Parlaments und des Rates hinsichtlich der Höchstgehalte an Rückständen von Acetamiprid, Cyantraniliprol, Cypermethrin, Cyprodinil, Difenoconazol, Ethephon, Fluopyram, Flutriafol, Fluxapyroxad, Imazapic, Imazapyr, Lambda-Cyhalothrin, Mesotrion, Profenofos, Propiconazol, Pyrimethanil, Spirotetramat, Tebuconazol, Triazophos und Trifloxystrobin in oder auf bestimmten Erzeugnissen
Kommisjonsforordning (EU) 2017/626 av 31. mars 2017 om endring av vedlegg II og III til europaparlaments- og rådsforordning (EF) nr. 396/2005 med hensyn til grenseverdier for rester av acetamiprid, cyantraniliprol, cypermetrin, cyprodinil, difenokonazol, etefon, fluopyram, flutriafol, fluksapyroksad, imazapik, imazapyr, lambdacyhalotrin, mesotrion, profenofos, propikonazol, pyrimetanil, spirotetramat, tebukonazol, triazofos og trifloksystrobin i eller på visse produkter
History
Disclaimer: EEA-Lex is provided for information purposes only. The information is not guaranteed or promised to be current or complete and is not intended to replace any applicable legal sources.